期刊文献+

硫酸软骨素的药理作用及应用研究进展 被引量:21

Progress in the Study of Pharmacology and Application of Chondroitin Sulfate
原文传递
导出
摘要 目的综述近年来硫酸软骨素的药理作用及应用研究进展。方法根据国内外相关文献,对硫酸软骨素的药理作用及应用进行整理与总结。结果与结论硫酸软骨素具有抗炎、免疫调节、心脑血管保护、神经保护、抗氧化、细胞黏附调节、抗肿瘤等多种药理学活性,目前临床上主要用于骨关节炎、心脑血管疾病及眼科疾病的预防和治疗,且长期服用毒副作用小,是很有开发潜力的药物。 OBJECTIVE To review the pharmacologic action and application of chondroitin sulfate. METHODS The pharmacologic action and application of chondroitin sulfate are reviewed based on the relevant articles published in recent years. RESULTS AND CONCLUSION Chondroitin sulfate has been demonstrated to possess varieties of pharmacological activities, including anti-inflammation, immunoregulation, anti-atherosclerosis, anti-oxidation, regulating cell adhesion and antitumor. So far, it is mainly used to prevent and treat osteoarthritis, cardiovascular and cerebrovascular diseases, as well as ophthalmological diseases in clinic with good tolerability and safety. Therefore, ehondroitin sulfate is a drug with great development potential.
出处 《中国药学杂志》 CAS CSCD 北大核心 2014年第13期1093-1098,共6页 Chinese Pharmaceutical Journal
基金 山东省自然基金高校 科研单位联合专项(ZR2011HL052) 山东省泰山学者药学特聘专家计划资助项目
关键词 硫酸软骨素 抗炎 免疫调节 心脑血管保护 chondroitin sulfate anti-inflammation immunoregulation anti-atherosclerosis
  • 相关文献

参考文献54

  • 1UEBELHART D, MALAISE M, MARCOI,ONGO R, et al. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: A one-year, randomized, double-blind, muhicenter study versus placebo [ J ]. Osteoarthritis Cartilage, 2004,12 (4) : 269- 276. 被引量:1
  • 2CLEGG D O, REDA D J, HARRIS C L, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis[J]. N Engl J Med, 2006,354(8) :795-808. 被引量:1
  • 3MARTIN M S, VAN SELl, S, DANTER J. Glucosamine and chondroitin: An appropriate adjunct treatment of symptomatic osteoarthritis of the knee[J]. Orthop Nurs, 2012,31(3) :160-166. 被引量:1
  • 4REGINSTER J Y. In people with hand osteoarthritis, chondroitin sulphate therapy for 6 months improves pain and function compared with placebo[ J]. Evid Based Med, 2012,17 (5) : 152-153. 被引量:1
  • 5DOMAGALA F, MARTIN G, BOGDANOWICZ P, et al. Inhibition of interleukin-1β-induced activation of MEK/ERK pathway and DNA binding of NF-kB and AP-1 : Potential mechanism for Diacerein effects in osteoarthritis[ J]. Biorheology, 2006,43(3) : 577-587. 被引量:1
  • 6DU SOUICH P, GARCIA A G, VERGES J, et al. Immunomodulatory and anti-inflammatory effects of chondroitin sulphate[J].J Cell Mol Med, 2009,13 ( 8 ) : 1451-1463. 被引量:1
  • 7HE Z X, JIN Y, ZHANG T M. Structure of chondroitin sulfate and its application in osteoarthritis therapy [ J]. 中国药学杂志,2012,47(5):387-391. 被引量:1
  • 8MCALINDON T E, LAVALLEY M P, GULIN J P, et al. Glucosamine and chondroitin for treatment of osteoarthritis : A systematic quality assessment and meta-analysis[ J]. JAMA, 2000,283 (11) : 1469-1475. 被引量:1
  • 9GABAY C, MEDINGER-SADOWSKI C, GASCON D, et al. Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: A randomized, double-blind, placebo-controlled clinical trial at a single center [ J ]. Arthritis Rheum, 2011,63 ( 11 ) :3383- 3391. 被引量:1
  • 10RUBIO-TERRES C. An economic evaluation of chondroitin sulfate and non-steroidal anti-inflammatory drugs for the treatment of osteoarthritis. Data from the VECTRA study[J]. Reumatol Clin, 2010,6(4) :187-195. 被引量:1

二级参考文献25

共引文献20

同被引文献266

引证文献21

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部